troglitazone has been researched along with Hydronephrosis in 1 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Hydronephrosis: Abnormal enlargement or swelling of a KIDNEY due to dilation of the KIDNEY CALICES and the KIDNEY PELVIS. It is often associated with obstruction of the URETER or chronic kidney diseases that prevents normal drainage of urine into the URINARY BLADDER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, K | 1 |
| Kanda, T | 1 |
| Homma, K | 1 |
| Tokuyama, H | 1 |
| Okubo, K | 1 |
| Takamatsu, I | 1 |
| Tatematsu, S | 1 |
| Kumagai, H | 1 |
| Saruta, T | 1 |
1 other study available for troglitazone and Hydronephrosis
| Article | Year |
|---|---|
Altered renal microvascular response in Zucker obese rats.
Topics: Acetylcholine; Animals; Arterioles; Blood Pressure; Chromans; Hydronephrosis; In Vitro Techniques; I | 2002 |